check_circleStudy Completed

Diabetes Mellitus, Type 1

Bayer Identifier:

Trial_9981

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Assessment of efficacy and tolerability of Acarbose in children under 16 years

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

5 - 16 Years
  • -

  • -

Trial summary

Enrollment Goal
73
Trial Dates
null - Today
Phase
N/A
Could I Receive a placebo
N/A
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteer
N/A

Trial design

Assessment of efficacy and tolerability of Acarbose in children under 16 years
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.